S.Amdt. 4347

SA 4347. Mr. RUBIO submitted an amendment intended to be proposed to
amendment SA 3867 submitted by Mr. Reed and intended to be proposed to
the bill H.R. 4350, to authorize appropriations for fiscal year 2022
for military activities of the Department of Defense, for military
construction, and for defense activities of the Department of Energy,
to prescribe military personnel strengths for such fiscal year, and for
other purposes; which was ordered to lie on the table; as follows:

At the end of subtitle C of title VII, add the following:

SEC. 744. ADDITIONAL AMOUNT FOR RAPID SCREENING UNDER
DEVELOPMENT OF MEDICAL COUNTERMEASURES AGAINST
NOVEL ENTITIES PROGRAM.

(a) Increase.--The amount authorized to be appropriated for
fiscal year 2022 by section 201 for research, development,
test, and evaluation is hereby increased by $4,500,000, with
the amount of the increase to be available for Advanced
Component Development & Prototypes, Research, Development,
Test, and Evaluation, Defense-Wide, for the Chemical and
Biological Defense Program-DEM/VAL, line 82 of the table in
section 4201, for the Development of Medical Countermeasures
Against Novel Entities program of the Defense Threat
Reduction Agency, to allow for the rapid screening of all
compounds approved by the Food and Drug Administration, and
other human-safe compound libraries, to identify optimal drug
candidates for repurposing as medical countermeasures for
coronavirus disease 2019 (commonly known as ``COVID-19'') and
other novel and emerging biological threats.

[[Page S7876]]

(b) Offset.--The amount authorized to be appropriated for
fiscal year 2022 by section 301 for operation and maintenance
is hereby decreased by $4,500,000, with the amount of the
reduction to be derived from Admin and Servicewide
Activities, Operations and Maintenance, Defense-Wide, for
Defense Media Activity, line 370 of the table in section
4301.
______